Petros Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
Petros Pharmaceuticals, Inc. (PTPI) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $42.00 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2026-04-15
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $42.00M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $30.00M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $17.90M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2025-12-31 | $42.00M 10-K · filed 2026-04-15 |
| 2024-12-31 | $30.00M 10-K · filed 2025-03-31 |
| 2023-12-31 | $17.90M 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |